I think this could be a great 2014 stock... getting in soon. still doing some DD
The companies already have an agreement for the development and commercialization of 5, 10, 15 and 20 mg strengths of generic Focalin XR. According to the deal, Intellipharmaceutics is responsible for all development costs of generic Focalin XR, while Par Pharma is responsible for bioequivalence costs, API costs, scale-up/stability costs and marketing of the product. Par Pharma is also responsible for all litigation expenses.
Additionally, according to the expanded agreement, Par Pharma will make an upfront payment to Intellipharmaceutics and the latter is also entitled to receive a share of profits from the sales of the drug.
"The Company has a ten year profit-sharing agreement with Par for the sale of dexmethylphenidate hydrochloride XR capsules in the U.S., which commences with the commercial launch of the product by Par. Additional details of the license agreement remain confidential."
i'm in FNMA from 0.8 and still holding. It is just not correct to compare IPCI with FNMA. The risk reward factor as you call it is totaly different. But great calls FNMA and IPCI are still strong buys imo.
Man you are crazy... Yes FNMA is a good stock to gamble, but it will be all or nothing. IPCI will never be nothing. For IPCI we are at the bottom now. If the USG says fannie and freddie have to go you will have ZERO dollar left. So take your blul sith tio the FNMA board.
words of CEO.... FOCALIN XR is the FIRST of 15 product to come on the market in the next 2 years... AT least 4 product in 2014. STRONG BUY
"We are extremely pleased about the filing of the stipulations of dismissal of the litigation involving our lead ANDA product, a generic version of the controlled-release drug Focalin XR.," commented Dr. Isa Odidi, CEO and co-founder of Intellipharmaceutics. "This action is an important step in bringing the first of the 15 products in our pipeline to market."
The parties, Intellipharmaceutics, Par, Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Celgene Corporation, Elan Corporation, PLC and Elan Pharma International Ltd., have also entered into license agreements in conjunction with the settlements of the litigation concerning the Company's generic drug application in the FDA for 5, 10, 15 and 20 mg strengths of dexmethylphenidate hydrochloride. Pursuant to the license agreements, Intellipharmaceutics and Par are granted fully paid up, royalty-free, non-exclusive licenses under the relevant patents pertaining to Focalin XR®. These licenses will permit Par to market, offer for sale, sell or take orders in the U.S. starting in October 2012 (or earlier in limited circumstances) for any of the Company's 5, 10, 15, and 20 mg strengths of dexmethylphenidate hydrochloride XR capsules that have received final FDA approval. The Company has a ten year profit-sharing agreement with Par for the sale of dexmethylphenidate hydrochloride XR capsules in the U.S., which commences with the commercial launch of the product by Par. Additional details of the license agreement remain confidential.
indeed, a market cap of 65 mil for a company with a FDA approval and a possible income of 40 mil/year from this approval. So making profit in 2014 and 4 more FDA approvals to come this year.... fair value??? imo around 250mil at this point or 12 dollar/share and 3 dollar extra for every new FDA approval in 2014...
picked up another 10000 this morning myself... And i tought my first buy at 3.8 was already crazyly low... it will be more than a double from here... (if you hold till end 2014 I say a 5 bagger)
yes, we can repeat it and repeat it time after time... but where do we need to do that for... 2014 will be SUPER for IPCI and the stockholders. Who doesn't want to listen will have to feel it (shorts). Holding till at least 2015.
SA autors are just writing for there own pockets... those that are short will bash and those that are long will pump... Do what you think is best.
would be great. But Sierra isn't the most correct reviewer out there... But still i realy think we WILL see news this week. glta
indeed. Bump... it is just a matter of time (short periode) to get this to 10 dollar and within years IPCI will trade over 30 dollar. Yes sign up for this 10 bagger. glta l